跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AA-RISEDRONATE DR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AA-RISEDRONATE DR
Authorized
STANDARD
AA-RISEDRONATE DR
aa pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1871af87fbe9172d
Company
aa pharma inc
Type
Standard
Approval Details
Approval Id
1871af87fbe9172d
Drug Approval Canada Name
AA-RISEDRONATE DR
Product Name
AA-RISEDRONATE DR
Status
Marketed
Status Date
2023-09-08
Original Market Date
2021-05-18
Din
02493268
Drug Class
Human
Dosage Form
Tablet (Delayed-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
92:24.00
Atc Original
M05BA07 RISEDRONIC ACID
Atc Name
m 05 ba 07
Aig Number
0135301003
Company Name
aa pharma inc
Company Address
UNIT 1, 1165 Creditstone Road, Vaughan, Ontario, Canada, L4K 4N7
Active Ingredients
RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE)
35 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1871af87fbe9172d
Type
Standard
Back to Health Canada Approvals